Assuming that ROS-neutralizing factors such as SOD enzymes were limiting the tumor inhibitory effects of DGAT1 antagonism, we next examined whether blocking the induction of SOD1 would augment the impact of DGAT1 inhibition on melanoma cell growth and survival. The gene discussed is DGAT1; the disease is melanoma.